Cost effectiveness analysis of expanding tuberculosis preventive therapy to household contacts aged 5-14 years in the Philippines

Author:

Ilaiwy Ghassan1,Keim-Malpass Jessica1,Tuppal Romella2,Ritua Alexander F.2,Bassiag Flordeliza R.2,Thomas Tania A.1

Affiliation:

1. University of Virginia

2. Isabela State University

Abstract

Abstract Background: Children aged 5-14 years who are household contacts of index pulmonary TB cases have limited coverage for TB preventive therapy (TPT) due to variable uptake of the national guideline recommendations in the Philippines. We conducted a cost effectiveness analysis evaluating the expansion of latent TB testing and treatment among pediatric (5-14 years) household contacts of index TB patients in the Philippines. Methods: Using a Markov state transition model, eligible household contacts (HHCs) age 5-14 years are screened for latent TB infection (LTBI) with either the tuberculin skin test (TST) or interferon gamma release assay (IGRA). Those who test positive are then simulated to receive one of the following TPT strategies: 6 months of daily isoniazid (6H), 3 months of weekly isoniazid and rifapentine (3HP), 3 months of daily isoniazid plus rifampicin (3HR) and the current practice of no testing or treatment for LTBI (NTT). The analysis assesses the projected cost and quality-adjusted life years (QALY) gained for every strategy from the perspective of the Philippines public healthcare system over a time horizon of 20 years. The total cost and gain in QALYs are presented as an incremental cost-effectiveness ratio (ICER) comparing cost per QALY gained for each strategy over NTT. Results: Our model estimates that expanding TPT coverage to HHCs aged 5-14 years would be cost effective with incremental cost-effectiveness ratios (ICERs) ranging from 1,024 $/QALY gained when using TST and 6H (Uncertainty range: 497 - 2,334) to 2,293 $/QALY gained when IGRA and 3HR are used (Uncertainty range: 1,140 – 5,203). IGRA cost would have to drop to $5.50 to achieve similar results to strategies using TST. These findings were robust to sensitivity analyses over a wide range of parameter values. Conclusion: Expanding TPT coverage to HHCs aged 5-14 years is cost effective when using TST and 6H closely followed by a strategy combining TST and 3HP. IGRA cost will require significant reduction to achieve results similar to TST.

Publisher

Research Square Platform LLC

Reference41 articles.

1. World Health Organization. Tuberculosis 2021 [Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.

2. United Nations Statistics Division. Global Sustained Development Goals Indicator Platform [Available from: https://unstats-undesa.opendata.arcgis.com/.

3. World Health Organization. WHO Operational Handbook on Tuberculosis. Module 1: Prevention - Tuberculosis Preventive Treatment 2020 [Available from: https://www.who.int/publications/i/item/9789240002906.

4. World Health Organization, UNICEF, United States Center for Disease Control. Stop TB, Partnership. United States Agency for International Development. Roadmap for Childhood Tuberculosis: Towards Zero Deaths Geneva, Switzerland2013 [Available from: https://apps.who.int/iris/bitstream/handle/10665/89506/9789241506137_eng.pdf.

5. The Philippines National Tuberculosis Program. TB Dashboard [Available from: http://racetb.doh.gov.ph/#!/layouts/dashboard-fullview.html.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3